Inspire Medical Systems, Inc. ( INSP) Q2 2026 Earnings Call August 3, 2026 5:00 PM EDT ...
DeepHealth received the Food and Drug Administration's 510(k) clearance for a tool that can detect and characterize lesions ...
Healthcare AI developer pairs ambient documentation, coding, and prior-auth automation with human-in-the-loop oversight ...
CARMEL, Ind., Aug. 04, 2026 (GLOBE NEWSWIRE) -- (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and ...
MarketBeat on MSN
Inspire Medical Systems Q2 earnings call highlights
Key Points Interested in Inspire Medical Systems, Inc.? Here are five stocks we like better. Second-quarter revenue fell 7.6% ...
Q2 2026 earnings call recap: 15% revenue growth, raised 2026 outlook, CMS/DRG reimbursement catalysts, and Q4 launch plans—read now.
MarketBeat on MSN
Exagen Q2 earnings call highlights
Key Points Interested in Exagen Inc.? Here are five stocks we like better. Record revenue and improved profitability: Exagen's second-quarter revenue rose 16% year over year to $19.9 million, while ...
In a recent conference call to discuss their second quarter 2026 results, Inspire Medical Systems announced that they had ...
On July 16, CMS published a significant Request for Information (RFI) to assess potential reforms to overhaul the American Medical ...
次世代 Virtual esports Project「ぶいすぽっ！」は、2026年7月14日(火)より、体験型ARG企画を展開しました。株式会社TwoGate（本社：東京都世田谷区、代表取締役：小林輝紀、以下「TwoGate」）は、本企画の立案およびゲーム制作にて協力いたしました。 【本企画の背景】 「ぶいすぽっ！」を日頃から楽しんでくださっているリスナーの皆さまに「これまでにない新しい体験を楽 ...
Olaparib's indications in the US include use as a single agent for patients with HRR gene-mutated mCRPC and in combination with abiraterone and prednisone for patients with BRCA-mutated mCRPC. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results